« Return to News | Technology Solutions | Study Conduct

PRI launches OnSite to increase clinical trial enrollment

Thursday, March 1, 2012 10:53 AM

Patient Recruiters International (PRI), a provider of direct patient access solutions for patient recruitment, has launched OnSite.

OnSite is a program specifically designed for building custom patient recruitment campaigns for individual clinical sites using the budget resources defined for their research study.

We are excited to launch OnSite to assist individual clinical sites with patient enrollment solutions while staying within their budget allocation,” said Larry Risen, president of PRI. “Under an OnSite program, PRI will develop and execute a custom patient recruitment program for clinical research sites incorporating our direct patient access strategies.”

OnSite is intended for engagement by clinical sites to increase patient enrollment into studies and enhance the efficiency of their efforts. Each OnSite program will include:

  • A strategic assessment and recommendation of the optimal recruitment strategies for that study and site specific situation.
  • Execution of at least two modalities of patient recruitment support by PRI.

Risen added, “Through OnSite, we are demonstrating our site-focused commitment with patient recruitment beyond what a sponsor may do through national campaign.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.